Amyloid in the cardiovascular system: a review

Area of Science:

• Cardiology
• Hematology
• Pathology

Background:

• Amyloidosis frequently impacts the cardiovascular system, leading to significant morbidity and mortality.
• Understanding the evolving nomenclature, classification, and pathogenesis is crucial for effective management.
• Cardiac involvement presents unique diagnostic and therapeutic challenges.

Purpose of the Study:

• To provide a comprehensive overview of the clinical and diagnostic strategies for amyloidosis, focusing on cardiac manifestations.
• To summarize recent advancements in the understanding of amyloidosis pathogenesis and classification.
• To discuss current and emerging treatment options and their prognostic implications.

Main Methods:

• Review of current literature on amyloidosis, emphasizing cardiovascular involvement.
• Discussion of diagnostic modalities, including non-invasive imaging and endomyocardial biopsies.
• Synthesis of information on recent therapeutic advances and prognostic factors.

Main Results:

• Amyloidosis is a significant cause of heart disease, requiring specific diagnostic approaches.
• Non-invasive methods and endomyocardial biopsy are key for diagnosing cardiac amyloidosis.
• Novel treatments are emerging, offering improved outcomes and prognostic insights.

Conclusions:

• A systematic approach integrating clinical, diagnostic, and therapeutic advancements is essential for managing cardiac amyloidosis.
• Early and accurate diagnosis significantly impacts patient prognosis.
• Ongoing research continues to refine treatment strategies and improve patient outcomes.